| Time | Duration |
| On-demand | 1 hour |
Learn how a leading precision diagnostic testing company is partnering with the nation’s premier high-acuity in-home care provider to accelerate and reduce the cost of clinical research - in the safety and comfort of patients’ homes.
Join Dr. Mohit Mathur, the Chief Medical Officer from Pathnostics, and Dr. Mark Prather, the Chief Executive Officer and Co-founder of DispatchHealth, for a panelist discussion on a unique approach in moving complex clinical trials and treatment into the home to create efficiencies and scale in patient recruitment, engagement, outcomes, and satisfaction.
Learning objectives
- Understand the innovation and importance of partnering to bring the power of the hospital to the comfort of home to accelerate clinical research
- Learn expert perspectives of how integrating home-based models can help reshape current and future research and commercial programs
- Explore why and how to bring complex clinical studies into the home with an overview of implementation, case examples, and performance KPIs
Access the full webinar
Please fill out the form below to unlock the full webinar.
Speakers:
Mark Prather
Chief Executive Officer and Co-founder - DispatchHealth
On course to reinvent our country’s approach to healthcare delivery, Dr. Mark Prather co-founded DispatchHealth in 2013 - a leading in-home medical provider offering the broadest and deepest level of care. With industry-leading patient satisfaction scores, DispatchHealth achieved medical cost savings exceeding $350 million in 2022. Dr. Prather completed his undergraduate studies at Vanderbilt University, attended medical school at UCLA, graduating Alpha Omega Alpha, and completed residency training in emergency medicine at Denver Health and Hospitals, where he served as Chief Resident. He has been involved in multiple patient-centric medical start-ups & founded one of the country’s largest emergency medicine physician groups.
Mohit Mathur
Chief Medical Officer - Pathnostics
Dr. Mathur has extensive experience with overseeing the medical and technical components of unique diagnostic solutions as Chief Medical Officer at Pathnostics. He previously served as Vice President of Medical Affairs at BioReference Laboratories, where during the COVID-19 pandemic he led efforts to bring Point of Care testing to patients in partnership with both government and private entities. Dr. Mathur worked for OPKO Health as a research scientist and also was NIH-funded for research on hypertrophic and restrictive cardiomyopathies.
